Your browser doesn't support javascript.
loading
High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.
Wang, Junhua; Bhalla, Akhil; Ullman, Julie C; Fang, Meng; Ravi, Ritesh; Arguello, Annie; Thomsen, Elliot; Tsogtbaatar, Buyankhishig; Guo, Jing L; Skuja, Lukas L; Dugas, Jason C; Davis, Sonnet S; Poda, Suresh B; Gunasekaran, Kannan; Costanzo, Simona; Sweeney, Zachary K; Henry, Anastasia G; Harris, Jeffrey M; Henne, Kirk R; Astarita, Giuseppe.
Afiliação
  • Wang J; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Bhalla A; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Ullman JC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Fang M; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Ravi R; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Arguello A; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Thomsen E; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Tsogtbaatar B; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Guo JL; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Skuja LL; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Dugas JC; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Davis SS; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Poda SB; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Gunasekaran K; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Costanzo S; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Sweeney ZK; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Henry AG; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Harris JM; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Henne KR; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
  • Astarita G; Denali Therapeutics, Inc., 161 Oyster Point Blvd, South San Francisco, CA 94080, USA.
Int J Mol Sci ; 21(15)2020 Jul 30.
Article em En | MEDLINE | ID: mdl-32751752
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Mucopolissacaridose II / Glicosaminoglicanos / Iduronato Sulfatase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Mucopolissacaridose II / Glicosaminoglicanos / Iduronato Sulfatase Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article